Granuloma Annulare in the Setting of Secukinumab
Joint Authors
Clark, Matthew L.
Tobin, Courtney A.
Sutton, Angela
Missall, Tricia Ann
Source
Case Reports in Dermatological Medicine
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-04-01
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Granuloma annulare (GA) is a common benign inflammatory skin condition classically presenting as skin-colored to erythematous dermal papules and annular plaques.
Histologically, GA displays a dermal granulomatous infiltrate with palisaded histiocytes surrounding focally altered collagen.
The exactly etiology of GA remains unknown, but it has been associated with trauma, various infections, diabetes mellitus, malignancy, thyroid disease, dyslipidemia, and several medications.
In 2017, a case of GA developing in a patient treated with the interleukin 17A antagonist secukinumab was reported.
Here we report a second case of GA in association with secukinumab use.
American Psychological Association (APA)
Clark, Matthew L.& Tobin, Courtney A.& Sutton, Angela& Missall, Tricia Ann. 2018. Granuloma Annulare in the Setting of Secukinumab. Case Reports in Dermatological Medicine،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1142816
Modern Language Association (MLA)
Clark, Matthew L.…[et al.]. Granuloma Annulare in the Setting of Secukinumab. Case Reports in Dermatological Medicine No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1142816
American Medical Association (AMA)
Clark, Matthew L.& Tobin, Courtney A.& Sutton, Angela& Missall, Tricia Ann. Granuloma Annulare in the Setting of Secukinumab. Case Reports in Dermatological Medicine. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1142816
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1142816
